Impact of the Table Height and the Operator's Height on the Level of Radiation Delivered to Interventional Cardiologists

In plain language

In 225 coronary procedures at one centre, interventional cardiologists' arm dosimeter readings averaged 53% lower when the table was set at 1126 mm or higher. This is an observational dose association, not a health outcome.

At a glance

Type of study: Original research, Dosimetry measurement study
Who was studied: Interventional cardiologists
Size: n = 225 procedures
Topics: Dosimetry and monitoring Dose reduction techniques
Summary based on: the abstract

What it found

Operators received a substantially lower radiation dose when the average table height was 1126 mm or more than when the table was lower.
Key figures: 53% lower
The dose reduction associated with higher table height remained significant after multivariate adjustment for operator.
The study analysed all invasive coronary procedures at a single centre over four months (March to June 2017).
Key figures: 225 invasive coronary procedures

Limits to keep in mind

Single-centre observational study over four months with a single dosimeter location (left arm); the abstract does not report adjustment for patient or procedural factors beyond operator, and the operator-height findings named in the title are not described.

Investigating Medical Radiation Awareness of Saudi Arabian Cardiologists in Catheterization Labs: (2026, Cross-sectional survey)
Radiation Exposure to Operators in Coronary Procedures Between Left Distal and Right Conventional Radial Access (2026, Randomized trial)
Real-time evaluation of operator eye lens radiation dose in interventional radiology: Effects of protective shield position and X-ray beam angle (2026, Dosimetry measurement study)
Two Central Nervous System Tumors in One Catheter Lab: Time to Rethink Radiation Protection (2026, Retrospective cohort study)
Comparative Effectiveness of Immersive Virtual Reality and Traditional Didactic Training on Radiation Safety in Medical Professionals: A Crossover Study (2025, Randomized trial)

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.